Popular Articles

Crucial support at 4,950
FII attitude may be key generic levitra

payday loans online
Make shareholding pattern of rating agencies public: Sebi body
The shareholding pattern of all credit rating agencies should be made public so that their relationship, if any, with rated companies, could be known, a body constituted by market regulator Sebi has recommended.

News of the day

MP plans to put food grain under licence system
Despite having a full-fledged dept and a corporation for PDS
Business Opportunities

Sun Pharma rises 2.3% on nod for generic drug

Sun Pharmaceutical Industries scrip rose Rs 32 or 2.3 per cent to close the day at Rs 1,429.20 on reports of US Food and Drug Administration’s (USFDA’s) nod for a generic drug. - Taro files lawsuit against Sun in US - Sun, Caraco to file 30 marketing applications for generics - Sun Pharma"s US arm facing more trouble - Sun Pharma settles patent dispute with Astra Zeneca - Sun Pharma uses own plants for US market after after Caraco trouble - Lawsuit filed against Sun Pharma"s US arm The company is believed to have received final approval to market Caffeine Citrate in injection and oral solution. The stock opened at Rs 1,397 and made an intra-day high of Rs 1,441.70. The stock is trading 11 per cent lower than its 52-week high of Rs 1,600 reached on 19 May, 2009.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):